Our novel findings show that (1) treatment with NHE‐1 inhibitor prior to ischemic injury or after reperfusion improves stroke outcomes in both WT and Hv1−/− SS rats and (2) proton channel Hv1 contributes to neurovascular injury and poor outcomes after stroke, especially when there is reperfusion. Here, SLC9A1 is linked to stroke disorder.